نتائج البحث

Population Pharmacodynamic Modeling of Epoetin Alfa in End-Stage Renal Disease Patients Receiving Maintenance Treatment Using Bayesian Approach.

• Authors : Nguyen LM; Department of Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, New York, USA.; Meaney CJ

Subjects: Anemia/Anemia/Anemia/*drug therapy ; Epoetin Alfa/Epoetin Alfa/Epoetin Alfa/*pharmacology ; Hematinics/Hematinics/Hematinics/*pharmacology

• Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Oct; Vol. 9 (10), pp. 596-605. Date of Electronic Publication: 2020 Sep 29.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial.

• Authors : Skrifvars MB; EPO-TBI Investigators and the ANZICS Clinical Trials Group

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*drug therapy ; Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*etiology ; Brain Injuries, Traumatic/Brain Injuries, Traumatic/Brain Injuries, Traumatic/*complications

• Source: Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2019 Feb; Vol. 63 (2), pp. 200-207. Date of Electronic Publication: 2018 Aug 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370270 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.

• Authors : Sühs KW; Department of Neurology, Medical School Hannover, Carl-Neuberg Str. 1, 30625 Hannover, Germany. .; Papanagiotou P

Subjects: Epoetin Alfa/Epoetin Alfa/Epoetin Alfa/*therapeutic use ; Hematinics/Hematinics/Hematinics/*therapeutic use ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*diagnosis

• Source: International journal of molecular sciences [Int J Mol Sci] 2016 Sep 30; Vol. 17 (10). Date of Electronic Publication: 2016 Sep 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Erythropoiesis-stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietin.

• Authors : Tsuruya K; a Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences , Kyushu University , Fukuoka , Japan ;

Subjects: Anemia/Anemia/Anemia/*drug therapy ; Epoetin Alfa/Epoetin Alfa/Epoetin Alfa/*administration & dosage ; Erythropoiesis/Erythropoiesis/Erythropoiesis/*drug effects

• Source: Renal failure [Ren Fail] 2016; Vol. 38 (3), pp. 390-6. Date of Electronic Publication: 2016 Jan 29.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effect of a More Permeable Dialysis Membrane on ESA Resistance in Hemodialysis Patients--A Pilot Investigation.

• Authors : Teatini U; Department of Nephrology and Dialysis, Bollate Hospital, AO Garbagnate M.se, Milan, Italy.; Liebchen A

Subjects: Anemia/Anemia/Anemia/*therapy ; Epoetin Alfa/Epoetin Alfa/Epoetin Alfa/*therapeutic use ; Erythropoietin/Erythropoietin/Erythropoietin/*therapeutic use

• Source: Blood purification [Blood Purif] 2016; Vol. 41 (1-3), pp. 80-6. Date of Electronic Publication: 2015 Nov 05.Publisher: S. Karger Country of Publication: Switzerland NLM ID: 8402040 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Hydroxyurea and EPO in Sickle Cell Disease (ACHiEvE-SCD)

• Authors : Carnegie Mellon University; American Society of Hematology; Julia Xu, Assistant Professor

• Source: Assessing Combination Hydroxyurea and Exogenous Erythropoietin in Sickle Cell Disease

تفاصيل العنوان

Vafseo Outcomes In-Center Experience (VOICE)

• Authors : Akebia Therapeutics

• Source: Safety of Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects: Vafseo Outcomes In-Center Experience

تفاصيل العنوان

Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data

• Authors : BOLAMAN, ALİ ZAHİT; Aslaner, Muzeyyen; GEDÜK, AYFER

Subjects: long-term; treatment response; Anemia

• Source: Turk J HaematolTurkish Journal of Hematology, Vol 40, Iss 2, Pp 92-100 (2023)

تفاصيل العنوان

Pharmacist-driven epoetin alfa-epbx dosing for hospitalized patients

• Authors : Eric, Linn; Heather, Morrison; Michael, Sanchez

Subjects: Epoetin Alfa; Cohort Studies; Hematinics

• Source: American Journal of Health-System Pharmacy. 80:687-691

تفاصيل العنوان

The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients

• Authors : Xinju Zhao; Liangying Gan; Fan Fan Hou

Subjects: erythropoietin resistance index; Male; Anemia

• Source: Ren FailRenal Failure, Vol 46, Iss 1 (2024)

تفاصيل العنوان